Art

J-GLOBAL ID：201702281975844470   Reference number：17A1202641

Polycystic ovary syndrome: early diagnosis and intervention are necessary for fertility preservation in young women with endometrial cancer under 35 years of age

多嚢胞性卵巣症候群:早期診断と介入が35歳以下の子宮内膜癌の若い女性における妊孕性温存に必要である

Author (7)： Okamura Yoshinori (Department of Obstetrics and Gynecology, Faculty of Life Sciences, Kumamoto University, Kumamoto, Japan) ,  Saito Fumitaka (Department of Obstetrics and Gynecology, Faculty of Life Sciences, Kumamoto University, Kumamoto, Japan) ,  Takaishi Kiyomi (Department of Obstetrics and Gynecology, Faculty of Life Sciences, Kumamoto University, Kumamoto, Japan) ,  Motohara Takeshi (Department of Obstetrics and Gynecology, Faculty of Life Sciences, Kumamoto University, Kumamoto, Japan) ,  Honda Ritsuo (Department of Obstetrics and Gynecology, Faculty of Life Sciences, Kumamoto University, Kumamoto, Japan) ,  Ohba Takashi (Department of Obstetrics and Gynecology, Faculty of Life Sciences, Kumamoto University, Kumamoto, Japan) ,  Katabuchi Hidetaka (Department of Obstetrics and Gynecology, Faculty of Life Sciences, Kumamoto University, Kumamoto, Japan)
Material： Reproductive Medicine and Biology  (Reprod Med Biol)
Volume： 16  Issue： 1  Page： 67-71  Publication year： Jan. 2017 
JST Material Number： L7364A  ISSN： 1445-5781  Document type： Article
Article type： 原著論文  Country of issue： Australia (AUS)  Language： ENGLISH (EN)

Thesaurus term： *endometrial carcinoma ,...
Semi thesaurus term： *Polycystic Ovary Syndrome ,...

Register(free) or Log In to access     To see more with JDream III (charged).   {{ this.onShowAbsJLink("http://jdream3.com/lp/jglobal/index.html?docNo=17A1202641&from=J-GLOBAL&jstjournalNo=L7364A") }}

Author keywords (5)： atypical endometrial hyperplasia ,  endometrial cancer ,  insulin resistance ,  organ-sparing treatments ,  polycystic ovary syndrome

JST classification (3)： Treatment for gynecologic and obstetrical diseases in general  (GS05010C) ,  Tumors(=neoplasms)of female genitalia and fetus  (GS04000K) ,  Treatment for tumors in general  (GE03031L)

Substance index (1)： Acetic acid medroxyprogesterone

Reference (21)：

• Azziz R, Woods KS, Reyna R, Key TJ, Knochenhauer ES, Yildiz BO. The prevalence and feature of the polycystic ovary syndrome in an unselected population. J Clin Endocrinol Metab. 2004;89:2745-2749.
• The Rotterdam ESHRE/ASRM-Sponsored PCOS Consensus Workshop Group. Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovarian syndrome (PCOS). Fertil Steril. 2004;81:19-25.
• Azziz R, Carmina E, Dewailly D, et al.; Task Force on the Phenotype of the Polycystic Ovary Syndrome of The Androgen Excess and PCOS Society. The Androgen Excess and PCOS Society criteria for the polycystic ovary syndrome: the complete task force report. Fertil Steril. 2009;91:456-488.
• Dokras A, Bochner M, Hollinrake E, Markham S, Vanvoorhis B, Jagasia DH. Screening women with polycystic ovary syndrome for metabolic syndrome. Obstet Gynecol. 2005;106:131-137.
• Yang S, Thiel KW, Leslie KK. Progesterone: the ultimate endometrial tumor suppressor. Trends Endocrinol Metab. 2011;22:145-152.

Terms in the title (5)： 多嚢胞性卵巣症候群 ,  早期診断 ,  子宮内膜癌 ,  女性 ,  妊孕性温存